Multicenter phase II study of docetaxel plus oxaliplatin combination chemotherapy in patients with advanced gastric cancer: Daegu Gyeongbuk Oncology Group

The present study was conducted to evaluate the efficacy and safety of a combination regimen of docetaxel plus oxaliplatin in patients with advanced gastric cancer. Patients with previously untreated metastatic or recurrent, measurable gastric cancer received intravenous docetaxel 65 mg m(−2) plus o...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, J G, Sohn, S K, Chae, Y S, Song, H S, Kwon, K-Y, Do, Y R, Kim, M K, Lee, K H, Hyun, M S, Ryoo, H M, Bae, S H, Park, K U, Lee, W S, Baek, J H, Chung, H Y, Yu, W
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 2008
Materias:
Clinical Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2243148/
https://www.ncbi.nlm.nih.gov/pubmed/18212754
http://dx.doi.org/10.1038/sj.bjc.6604188

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2243148/
https://www.ncbi.nlm.nih.gov/pubmed/18212754
http://dx.doi.org/10.1038/sj.bjc.6604188

Ejemplares similares